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Abstract Recombinant thymidine kinase from Herpes sim- 
plex virus type 1 (ATP:thymidine 5'-phosphotransferase; EC 
2.7.1.21), an enzyme of therapeutic importance, was purified and 
crystallized in an N-terminally truncated but still fully active 
form. The three-dimensional structure was solved by X-ray dif- 
fraction analysis at 3.0 ~. resolution using isomorphous replace- 
ment. The chain fold is presented together with the bound sub- 
strates thymidine and ATP. Three chain segments at the surface 
could not be located. The chain fold, the location of the substrates 
and presumbly also the catalytic mechanism resemble the well- 
known adenylate kinases. 
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1. Introduction 
Thymidine kinase (TK) is the key enzyme in the pyrimidine 
salvage pathway. Whereas the mammalian cytosolic isozyme 
catalyzes the transfer of the y-phosphate from ATP .Mg 2+ to 
thymidine to produce thymidine monophosphate (dTMP), the 
virus encoded isozyme repeats this step yielding thymidine di- 
phosphate (dTDP) [1,2]. Moreover, host TK  accepts only py- 
rimidines, whereas viral TK  also accepts purines, and even 
those carrying an acyclic ribose analogue such as the prodrugs 
acyclovir or gancyclovir. In virus-infected cells these prodrugs 
are activated to their triphosphates and incorporated into the 
viral DNA resulting in chain termination [3]. As the activation 
is catalyzed nearly exclusively by the viral TK, only infected 
cells are hit [4]. Moreover, TK  is used in the so-called 'virally 
directed enzyme prodrug therapy', where the gene for viral TK  
is introduced to tumor cells followed by administration of gan- 
cyclovir. The viral TK  renders the proliferating cells susceptible 
to this treatment by transforming ancyclovir into a cytotoxic 
drug. 
The structure of the viral TK  is expected to provide a basis 
for rational design of more efficient substrates, inhibitors or 
enzymes for severe Herpes viral infections and for the gene 
therapy approach on tumors. Here, we describe the crystal 
structure of a recombinant viral TK  from Herpes simplex virus 
type 1 (HSV1) expressed as fusion protein in E. eoli. The en- 
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zyme is N-terminally truncated by 33 residues, but still fully 
active. It is dimeric with Mr -- 2 x 37,129. 
2. Materials and methods 
2.1. Materials 
Enzymes used in molecular cloning were obtained from Boehringer- 
Mannheim. Thrombin, glutathione-agarose, ATP-agarose and other 
chemicals were purchased from Sigma. The plasmid pGEX2T was 
purchased from Pharmacia. The plasmid pBR322-TK containing the 
gene for TK from HSV1 was a gift from S. McKnight (Baltimore). 
E. coli strain 71/18 was the host for cloning procedures. The TK- 
deficient E. coli strain KY895 was used for expression of the fusion 
protein glutathione-S-transferase-TK. 
2.2. Expression and purification 
The bacterial expression vector pGEX2T-TK was constructed as 
described earlier [5]. Purification of the glutathione-S-transferase-TK 
fusion protein was carried out by glutathione affinity chromatography, 
thrombin cleavage followed by ATP affinity chromatography as de- 
scribed [2,6]. Expression and purification were monitored by SDS- 
PAGE using the Phast System from Pharmacia; the enzyme activity was 
measured as described [6]. Protein concentrations were determined ac- 
cording to Bradford [7] and by amino acid analysis. 
2.3. Crystallization 
For crystallization, we used the hanging drop method at 4°C. The 
purified N-terminally truncated protein started at residue position 34, 
where the viral TK is sensitive to thrombin cleavage. The truncation 
was confirmed by N-terminal sequence analysis. The enzyme was kept 
in a buffer containing 10 mM MOPS at pH 7.5, 1 mM EDTA, 0.1% 
Triton X-100, 2 mM DTT, 50/tM thymidine and 10 mM ATP. Using 
a centricon the protein was concentrated to 40 mg/ml and subsequently 
diluted with the same buffer (but without Triton X-100 and ATP) to 
5 mg/ml. The resulting protein solution was mixed in a 1 : 1 ratio with 
the crystallization buffer (40-50 mM KH2PO4, pH 5.5, 1 mM DTT, 50 
gM thymidine, 15 20% PEG-8000, 0.02% NAN3) to give a drop of 5 pl. 
The reservoir contained the crystallization buffer. 
Crystals appeared after 3 days and grew within 1 2 weeks to sizes of 
about 300 x 200 x 200 pm 3. They belong to space group I41 with 
a = b = 83.4 A, c = 156.7 A and one subunit of the dimeric enzyme in 
the asymmetric unit. At 67% the solvent content is rather high. The 
crystals are reasonably stable in the X-ray beam and diffract o 2.8 A 
resolution under X-radiation from a rotating anode and to 2.5 A at a 
synchrotron (EMBL-outstation, DESY, Hamburg). They differ from 
crystals of TK from HSV1 reported earlier [8]. 
2.4. Data collection and phase determination 
Data were collected using a rotating anode (model RU200B, Rigaku) 
together with a multi-wire area detector (model X1000, Siemens). Data 
processing was with program XDS [9]. Heavy atom derivatives were 
produced by soaking (Table 1). The difference Pattersons of all 3 deriv- 
atives were clearly interpretable. Unfortunately, all of them were single 
site derivatives with mercury bound to Cys-336. The heavy atom pa- 
rameters were refined with program PHASIT from the PHASES pack- 
age (W. Furey, 1991; University of Pittsburgh, PA, USA) yielding an 
essentially single isomorphous replacement electron density map. This 
map was poor, but could be strongly improved by solvent-flattening 
using program BNDRY of PHASES. The resulting map allowed us to 
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place the polypeptide chain unambiguously, except for three segments 
at the surface. Model refinement has been started. 
3. Results and discussion 
3.1 Chain foM 
The current model consists of 2154 non-hydrogen atoms and 
both substrates, thymidine and ATE Model refinement with- 
out water has begun, the present R-factor is 28.9%. All of the 
residues lie in allowed, and 71% in most favoured regions of the 
Ramachandran plot (program PROCHECK in the XPLOR 
package). The model includes 284 of the 343 residues of the 
N-terminally truncated TK. Residues 34-49, 146-151 and 251 
287 were not yet modeled because of low density in the initial 
solvent-flattened s.i.r, map. Still, the chain connectivity is
unique. The lacking defined conformation of residues 3449 
and 146-151 may be caused by the truncation of residues 1-33. 
The secondary structures could be clearly assigned and the 
sequence could be well fitted to the density. 
The overall fold of TK is illustrated in Fig. 1. The core of the 
protein contains a parallel 5-stranded ]J-sheet (b5, b4, bl, b3 
and b2) in the same arrangement as in the adenylate kinases 
[10]. The sheet is surrounded by 12 c~-helices (al to a12) cover- 
ing both sides. Thus, TK belongs to the ~/fl proteins. Several 
s-helices (e.g. al, a2, a7, a8, and al 1) have equivalent counter- 
parts in the adenylate kinases. Between helices a8 and a9 the 
conformation of 37 residues is not yet established due to lack 
of appropriate density. Using program PREDICT (package 
HUSAR, DKFZ, Heidelberg) with 4 current prediction meth- 
ods no secondary structure is suggested for this chain segment. 
Here, the chain appears to form an extra domain consisting of 
the omitted residues together with helices a9, al0 and loop 
a9-al0. As there is not much density, this domain may well be 
mobile. 
The subunit arrangement i  the dimer is depicted in Fig. 2. 
Table 1 
Data collection and phase determination byisomorphous replacement 
Native Derivatives 
HMSA a PCMPS- PCMPS- MC c 
1 b 2 b 
Resolution [A] 3.0 3.5 3.0 3.5 3.2 
Number of crystals 1 1 1 1 1 
Completeness [%] 80 63 76 80 81 
Outermost hell [%] 58 51 76 49 61 
Rsr," [%]d 9.F 8.2 11.9 8.7 8.8 
Rna t [%]f 17 31 18 16 
Heavy atom sites 
x 0.085 0.085 0.084 0.085 
y 0.109 0.112 0.110 0.105 
z 0.750 0.750 0.750 0.750 
Rel. occupancy 77 61 62 81 
Phasing power 1.6 1.4 1.6 1.4 
"The soak was with I mM 3,5-(hydroxymercufi)salicylic a id for 1 day. 
b Both soaks were with 1 mM p-(chloromercuri)-phenyl-sulfonic acid 
for 3 days. Labels 1 and 2 refer to data collection with synchrotron 
radiation (EMBL-outstation, Hamburg) and rotation anode, respec- 
tively. 
CThe soak was with 1 mM mercurichrome for2 days. 
dRsy m = ~r 'h , i l l (h) i -  < l(h) > ]/~V'h, i l (h) i .  
e The value corresponds to all collected data to 2.9 A resolution as given 
by program MERGE (B. Dijkstra, Groningen, The Netherlands). The 
outermost hell 3.0-2.9 A was of low quality and has been discarded. 
rR,a t= 2"~r[FdeFi, - Fnativ][.,~(Fderi v + Fxlativ ). 
( 
[ 376 
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Fig. 1. Sketch of the chain fold of thymidine kinase from Herpes 
simplex virus type 1. To avoid crossovers the sketch is somewhat sim- 
plified rendering some helix positions disputable. All ,B-strands (quad- 
rangles) run towards the viewer, the orientations ofthe helices (circles) 
are indicated by the arrows. Dashed lines denote chain segments that 
are not yet modeled. The central residues of secondary structure le- 
ments bl, b2, b3, b4, b5, al, a2, a3, a4, a5, a6, a7, a8, a9, al0, al 1, and 
a12 are 52, 79, 159, 203, 326, 67, 87, 103, 131, 172, 190, 215, 239, 292, 
314, 340, and 364, respectively. 
Helices a4 and a6 are at the center of the interface. Further- 
more, the interface includes loop a2-a3, part of loop a9-al0, 
and the ends of helices al0 and a12. As illustrated by appropri- 
ate model orientation i Fig. 2, the interface is large and almost 
planar. It contains a twofold crystallographic axis. Thymidine 
binds closer to the dimer interface than ATE 
3.2 Active center 
The active center is defined by the bound substrates; a close- 
up view is given in Fig. 3. In spite of the presence of both 
substrates, no reaction occurs because EDTA in the buffer 
removes the required Mg 2+. A crucial part of the active center 
is the glycine-rich loop connecting fl-strand bl with helix al. 
This loop contains the sequence fingerprint -G-X-X-G-X-G-K- 
T- forming a giant anion hole [11] that accomodates the fl- 
phosphoryl group of ATP (Fig. 3) like in the adenylate kinases 
[12] and in numerous other nucleotide binding proteins [13]. As 
deduced from the adenylate kinases the lysine of this fingerprint 
is essential for phosphoryl transfer during catalysis [12]. 
The substrate thymidine has clear density in a pocket formed 
by helices a3, a4 (kinked at Pro-131) and a5. Its ribose moiety 
points towards the glycine-rich loop. The tight binding corre- 
sponds to the low Km-value of 0.2 ¢tM for this nucleoside [2]. 
In front of the ribose moiety of thymidine (view of Fig. 3) there 
is space for an additional phosphoryl group, such that also 
dTMP can be accomodated assubstrate. ATP binds at the giant 
anion hole and extends along helix a7 (Fig. 3). Its binding site 
is much more open than the thymidine site in agreement with 
the much higher Kin-value of 118/.tM for ATP [14]. Obviously, 
Mg 2+ is not required for ATP binding in correspondence with 
the findings for adenylate kinases [15]. 
The bottom of the active site (view of Fig. 3) includes e- 
quence motif-F~61-D-R-H-, which is highly conserved among 
K. Wild et al. IFEBS Letters 368 (1995) 289-292 291 
Fig. 2. Stereo-view of the current Ca-backbone ofdimeric thymidine kinase from Herpes implex virus type 1 with numbering and the bound substrates 
thymidine and ATP. The dashed lines indicate regions of low density which have not yet been modeled. The chosen orientation emphasizes the 
planarity of the interface. The two-fold axis runs from the lefthand side in the front to the right hand side in the rear. 
the thymidine kinases [16,17]. It consists of the C-terminal end 
offl-strand b3 and part of the following loop. In the adenylate 
kinases the equivalent of Asp-162 fixes the Mg 2+ required for 
catalysis via water molecules [18]. Furthermore, the change 
Asp-162--,Asn in TK  from HSV1 yields a completely inactive 
enzyme [19]. Arg-163 points towards the ribose of thymidine 
and is likely to bind the additional phosphoryl group of dTMP. 
A similarly located arginine in the adenylate kinases binds to 
the s-phosphate of AMP [12]. A natural mutation (to Gln) of 
the respective arginine in TK of Varicella zoster virus resulted 
in acyclovir esistance [20], corroborating its importance for the 
phosphorylation of dTMP. 
In conclusion, we find that the presented preliminary struc- 
ture in combination with the extensive knowledge about the 
distantly related adenylate kinases provides already a solid 
framework for understanding the catalysis of the viral TK. 
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